Company news

Telesis Bio, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis

May 28, 2025

Telesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA Synthesis

March 18, 2025

Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market

September 9, 2024

Calls

Decks

The 5 newest of 6 decks. Every deck is listed under its year.